Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Primary Myelofibrosis × daratumumab × Clear all

Sponsor

Conditions

Multiple Myeloma 42 Recurrence 5 Leukemia, Myeloid, Acute 4 Waldenstrom Macroglobulinemia 2 Immunoglobulin Light-chain Amyloidosis 2 Carcinoma, Non-Small-Cell Lung 2 Various Advanced Cancer 1 Triple Negative Breast Neoplasms 1 Smoldering Multiple Myeloma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmacytoma 1 Paraproteinemias 1 Pancreatic Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Microsatellite Unstable Colorectal Cancer 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Leukemia, Myeloid 1 Leukemia, Monocytic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hypergammaglobulinemia 1 Hodgkin Disease 1 Amyloidosis 1

Interventions

fludarabine phosphate 31 Cyclophosphamide 27 Mycophenolic Acid 22 Whole-Body Irradiation 21 Tacrolimus 21 Peripheral Blood Stem Cell Transplantation 19 Busulfan 19 ruxolitinib 17 Antilymphocyte Serum 16 fludarabine 14 Melphalan 12 Methotrexate 11 Cyclosporine 10 thymoglobulin 9 Cord Blood Stem Cell Transplantation 7 Sirolimus 6 Radiotherapy 6 Etoposide 6 Azacitidine 6 Granulocyte Colony-Stimulating Factor 5 Stem Cell Transplantation 4 Cyclosporins 4 pomalidomide 3 parsaclisib 3 Surveys and Questionnaires 3 Rituximab 3 Prednisone 3 Filgrastim 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 sargramostim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡